DLK Investment Management LLC lifted its stake in DarioHealth Corp. (NASDAQ:DRIO – Free Report) by 40.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 141,657 shares of the company’s stock after purchasing an additional 41,107 shares during the period. DLK Investment Management LLC owned about 0.42% of DarioHealth worth $111,000 at the end of the most recent quarter.
Separately, Appian Way Asset Management LP increased its holdings in DarioHealth by 3.1% during the 2nd quarter. Appian Way Asset Management LP now owns 1,375,880 shares of the company’s stock worth $1,637,000 after purchasing an additional 41,738 shares during the period. Institutional investors own 33.39% of the company’s stock.
DarioHealth Stock Up 6.7 %
Shares of DRIO stock opened at $0.69 on Monday. DarioHealth Corp. has a twelve month low of $0.63 and a twelve month high of $2.60. The stock has a fifty day simple moving average of $0.78 and a two-hundred day simple moving average of $0.92. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35.
DarioHealth Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Recommended Stories
- Five stocks we like better than DarioHealth
- Differences Between Momentum Investing and Long Term Investing
- 3 Must-Watch Semiconductor Stocks as NVIDIA Takes a Breather
- 3 Dividend Kings To Consider
- Small-Cap Titans: 3 Russell 2000 Winners for 2025
- About the Markup Calculator
- Unusual Call Option Volume in US Steel: Potential Upside Ahead?
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.